Identification of a co-target for enhancing efficacy of sorafenib in HCC through a quantitative modeling approach
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a co-target for enhancing efficacy of sorafenib in HCC through a quantitative modeling approach
Authors
Keywords
-
Journal
FEBS Journal
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-23
DOI
10.1111/febs.14641
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International incidence and mortality trends of liver cancer: a global profile
- (2017) Martin C. S. Wong et al. Scientific Reports
- Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues
- (2017) Yanyan Gao et al. Scientific Reports
- Probing the Druggability Limits for Enzymes of the NAD Biosynthetic Network in Glioma
- (2016) Jyothi Padiadpu et al. Journal of Chemical Information and Modeling
- Transketolase counteracts oxidative stress to drive cancer development
- (2016) Iris Ming-Jing Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying and Tackling Emergent Vulnerability in Drug-Resistant Mycobacteria
- (2016) Jyothi Padiadpu et al. ACS Infectious Diseases
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
- (2016) Xiaoqiang Li et al. Scientific Reports
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- Reactive Oxygen Species in Cancer: A Dance with the Devil
- (2015) Paul T. Schumacker CANCER CELL
- Physical and Mathematical Modeling in Experimental Papers
- (2015) Wolfram Möbius et al. CELL
- Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer
- (2015) Yi Sun et al. Nature Communications
- DrugComboRanker: drug combination discovery based on target network analysis
- (2014) L. Huang et al. BIOINFORMATICS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS
- (2014) Asem I. Fitian et al. LIVER INTERNATIONAL
- BioModels: ten-year anniversary
- (2014) Vijayalakshmi Chelliah et al. NUCLEIC ACIDS RESEARCH
- Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient
- (2014) Ling Ye et al. PLoS One
- Glutathione S-conjugates as prodrugs to target drug-resistant tumors
- (2014) Emma E. Ramsay et al. Frontiers in Pharmacology
- Glutathione: new roles in redox signaling for an old antioxidant
- (2014) Katia Aquilano et al. Frontiers in Pharmacology
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
- (2013) Q. Huang et al. CANCER RESEARCH
- Model of Tryptophan Metabolism, Readily Scalable Using Tissue-specific Gene Expression Data
- (2013) Anne-Kristin Stavrum et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Metabolic control analysis of respiration in human cancer tissue
- (2013) Tuuli Kaambre et al. Frontiers in Physiology
- Biological systems modeling of metabolic and signaling networks
- (2013) Joseph A Wayman et al. Current Opinion in Chemical Engineering
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Ontogeny and Sorafenib Metabolism
- (2012) E. I. Zimmerman et al. CLINICAL CANCER RESEARCH
- Network approaches to drug discovery
- (2012) Nagasuma Chandra et al. Expert Opinion on Drug Discovery
- Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors
- (2012) Olaf Neumann et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
- (2012) R. Coriat et al. MOLECULAR CANCER THERAPEUTICS
- NCBI GEO: archive for functional genomics data sets—update
- (2012) Tanya Barrett et al. NUCLEIC ACIDS RESEARCH
- HMDB 3.0—The Human Metabolome Database in 2013
- (2012) David S. Wishart et al. NUCLEIC ACIDS RESEARCH
- The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
- (2011) Katherine A. McGlynn et al. Clinics in Liver Disease
- A mathematical modelling approach to assessing the reliability of biomarkers of glutathione metabolism
- (2011) Suzanne Geenen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- SABIO-RK--database for biochemical reaction kinetics
- (2011) U. Wittig et al. NUCLEIC ACIDS RESEARCH
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- The Clinical Pharmacology of Ethacrynic Acid
- (2009) Janos Molnar et al. AMERICAN JOURNAL OF THERAPEUTICS
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
- (2009) Desheng Lu et al. PLoS One
- Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance
- (2008) Karthik Raman et al. BMC MICROBIOLOGY
- Metabolic Control Analysis: A Tool for Designing Strategies to Manipulate Metabolic Pathways
- (2008) Rafael Moreno-Sánchez et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope
- (2008) Robin K. Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Glutathione: Overview of its protective roles, measurement, and biosynthesis
- (2008) Henry Jay Forman et al. MOLECULAR ASPECTS OF MEDICINE
- Regulation of glutathione synthesis
- (2008) Shelly C. Lu MOLECULAR ASPECTS OF MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- A mathematical model of glutathione metabolism
- (2008) Michael C Reed et al. Theoretical Biology and Medical Modelling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now